Current and Evolving Treatments of Genotype 1 Hepatitis C Virus

Research output: Contribution to journalReview articlepeer-review

15 Scopus citations


Development of antiviral agents that target the hepatitis C virus (HCV) has improved the success and tolerability of treatment, especially for patients with HCV genotype 1 infection. The new treatment options mean that clinicians are better able to prevent complications from chronic HCV infection. The field of direct-acting antiviral therapies for HCV infection continues to advance at a rapid pace, and many more potential treatment regimens are being investigated. This article presents a summary of the current treatments available for patients infected with HCV genotype 1 and looks ahead to those that may play a role in the future.

Original languageEnglish (US)
Pages (from-to)825-843
Number of pages19
JournalGastroenterology Clinics of North America
Issue number4
StatePublished - Dec 2015


  • Cirrhosis
  • Hepatitis
  • Hepatitis C
  • Ledipasvir antiviral
  • Simeprevir
  • Sofosbuvir

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Current and Evolving Treatments of Genotype 1 Hepatitis C Virus'. Together they form a unique fingerprint.

Cite this